No abstract

Knowledge ofthe genetic structure of germplasm collections is crucial for conservation and efficient use of genetic resources. This study assessed the diversity and genetic structure of a collection of landraces of Spanish durum wheat {Triticum turgidum L.) using several marker systems and correlated the diversity and agromorphological traits with geographic and climatic features. Analyzed genotypes were separated into nine populations, with moderate to great genetic divergence among them. The three subspecies dicocoon, turgidum, and durum present in the collection largely determined the clustering of the populations. Genotype variation was lower in dicoccon and turgidum than in durum. Genetic differentiation by the agroecological zone of origin was greater in dicoocon and turgidum than in durum. Diversity arrays technology markers revealed two geographic substructures, east-west for diooccon and northeast-southwest for turgidum. The ssp. durum had a more complex structure, consisting of seven populations with high intrapopulation variation. Diversity arrays technology markers allowed the detection of subgroups within some populations, with agromorphological and gliadin differences, and distinct agroecological zones of origin. Two different phylogenetic groups were detected, revealing that some durum accessions were more related to ssp. turgidum from northern Spain while others seem to be more related to durum wheats from North Africa.

The allelic variation at seven prolamin loci involved in quality has been studied in a set of durum wheat landraces from all the Spanish regions where this crop has been traditionally cultivated. The genetic variability was higher than that found in other germplasm collections. All the loci, except Glu-B2, displayed a genetic variability higher than 0.62, with Glu-3 the most polymorphic. In total, five alleles were studied at Glu-A1, nine at Glu-B1, 15 at Glu-A3, 18 at Glu-B3, two at Glu-B2, and eight at Gli-A1 and Gli-B1. New allelic variants not previously identified in durum wheat were detected. The 30 different genotypes of B low-molecular-weight (B-LMW) glutenin subunits analysed, of which 25 are novel, provide an important source of genetic variability for quality breeding. Protein patterns for convars. durum and turgidum, and for the North and South of Spain were identified for the loci with significant influence on quality. Higher variability was observed in convar. turgidum and in the North zone than in convar. durum and the South, respectively, mainly for the Glu-B1 and Glu-B3. Also, convar. turgidum appeared to be a valuable source for new alleles for the LMW glutenin subunits. Wheats from the South were, however, more diverse for prolamins encoded at Glu-A3.Additional key words: convar. durum, convar. turgidum, germplasm, LMW patterns, prolamin alleles, quality breeding. ResumenVariación genética de las gluteninas y gliadinas asociadas con calidad en variedades locales españolas de trigo duro (Triticum turgidum L. ssp. turgidum) Se ha estudiado la variación alélica en siete loci de prolaminas relacionados con la calidad en un grupo de variedades locales de trigo duro procedentes de todas las provincias españolas donde se cultivaba tradicionalmente. La variabilidad genética encontrada fue mayor que la observada en otras colecciones de germoplasma. Todos los loci, excepto el Glu-B2, mostraron una variabilidad genética mayor que 0,62, siendo los Glu-3 los más polimórficos. En total se estudiaron cinco alelos en el Glu-A1, nueve en el Glu-B1, 15 en el Glu-A3, 18 en el Glu-B3, dos en el Glu-B2 y ocho en el Gli-A1 y Gli-B1. Se han detectado variantes alélicas nuevas que no se habían identificado antes. Los 30 genotipos diferentes analizados de subunidades B de gluteninas de bajo peso molecular (B-LMW), de los cuales 25 son nuevos, representan una fuente importante de variabilidad genética para la mejora de la calidad. Se identificaron patrones de proteínas para las convars. durum y turgidum, y para el norte y sur de España para los loci con influencia significativa en calidad. En la convar. turgidum y en el norte se observó mayor variabilidad que en la convar. durum y en el sur, respectivamente, principalmente en el Glu-B1 y Glu-B3. Además, la convar. turgidum parece ser una fuente valiosa de nuevos alelos para las subunidades LMW de gluteninas. Sin embargo, los trigos del sur son más diversos para las prolaminas codificadas en el Glu-A3.

Gliadin and glutenin electrophoresis of F2 progeny from four crosses of durum wheat was used to analyse the linkage relationships between prolamin genes on chromosomes 1A and 1B. The results showed that these genes are located at the homoeoallelic lociGlu-1,Gli-3,Glu-3 andGli-1. The genetic distances between these loci were calculated more precisely than had been done previously for chromosome 1B, and the genetic distances betweenGli-A3,Glu-A3 andGli-A1 on chromosome 1A were also determined. Genes atGli-B3 were found to control someω-gliadins and one B-LMW glutenin, indicating that it could be a complex locus.

BackgroundOnabotulinumtoxinA (OnabotA) is effective in Chronic Migraine (CM) during first year of treatment and longer. In real clinical setting, CM patients with acute Medication Overuse (MO) or concurrently receiving oral preventatives are treated with OnabotA. We aim to assess evolution of CM patients beyond first year on OnabotA.MethodsData were retrospectively collected in three headache units. We analyzed cases who had received at least five sessions of OnabotA according to PREEMPT protocol. We continued OnabotA therapy when a reduction of number of headache days of at least 30% was achieved.ResultsWe included 115 patients (98 females, 17 males) who completed 7.6 ± 2.3 (5–13) OnabotA procedures. Previously they had not responded to topiramate and, at least, one other preventative. Age at inclusion was 45.3 ± 12 (14–74) years, and latency between CM onset and OnabotA therapy was 43.1 ± 38.2 (6–166) months. At first OnabotA session 92 patients (80%) fulfilled MO criteria and 107 (93%) received a concurrent oral preventative. In 42 cases (36.5%) OnabotA dose was increased over 155 units. After first year in 57 out of 92 patients (61.9%) MO was discontinued. Among those receiving preventatives, in 52 out of 107 they were retired (48.6%). In 22 cases (19.1%) OnabotA administration was delayed to the fourth or fifth month and in 12 (10.4%) it was temporally stopped. Finally, in 18 patients (15.7%) OnabotA was discontinued due to lack of efficacy beyond first year of treatment.ConclusionOur results suggest that discontinuation of acute medication overuse and oral preventive therapies are achievable objectives in long-term using of OnabotA in CM patients.